Hemant Kumar Email & Phone Number

Hemant is a seasoned biotech executive recognized as Global Expert in CMC Accelerated Development, Reducing Risks and Delays in the Translation of Gene Therapy, and Complex Biologics Innovations into Regulated Products. He is passionate about developing life-changing therapies for patients and delivering value for shareholders in complex and dynamic environments.He has a stellar 25+ years of track record with start-ups and Fortune 500 companies(Sanofi, Merck, Lonza) in leading advanced non-viral (ot-LNP) & viral AAV Gene Therapies, Vaccines, ADCs, and Biopharmaceuticals by integrating next generation platform technologies and workflows for accelerated development of innovative drug targets from early stage through licensure. Experienced leader in building high-performance teams, driving operational efficiency, value creation, and growing products in global competitive pharma space. Strong track record of leading technical & non-technical functions including successful interactions with FDA, EMA, WW Health Authorities resulting in global approvals for several innovative modalities.He recently served as the Chief Technology & Manufacturing Officer at Genprex, a clinical-stage gene therapy company focused on cancer and diabetes. He was responsible for driving the innovation, development, and commercialization of novel gene therapies using AAV and LNP platforms, as well as managing the external network of CDMOs and CROs.

Listed skills include Biopharmaceuticals, Biotechnology, Vaccines, Change Control, and 4 others.